Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 9926
TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM181133(US9138393, Allopurinol | US9144538, Allopurinol | ...)
Affinity DataIC50: 2.31E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233807(CHEMBL4078844 | US11021454, Compound 6c)
Affinity DataIC50: 3.27E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233811(CHEMBL4101271 | US11021454, Compound 6f)
Affinity DataIC50: 3.86E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233803(CHEMBL4103606 | US11021454, Compound 5b)
Affinity DataIC50: 3.90E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233803(CHEMBL4103606 | US11021454, Compound 5b)
Affinity DataIC50: 3.99E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233820(CHEMBL4104607 | US11021454, Compound 6d)
Affinity DataIC50: 4.20E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233808(CHEMBL4086701 | US11021454, Compound 6e)
Affinity DataIC50: 4.51E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233806(CHEMBL4102185 | US11021454, Compound 6a)
Affinity DataIC50: 4.52E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233806(CHEMBL4102185 | US11021454, Compound 6a)
Affinity DataIC50: 4.81E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233811(CHEMBL4101271 | US11021454, Compound 6f)
Affinity DataIC50: 4.98E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233815(CHEMBL4071391 | US11021454, Compound 6b)
Affinity DataIC50: 5.61E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM7460(2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone;...)
Affinity DataIC50: 6.00E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233820(CHEMBL4104607 | US11021454, Compound 6d)
Affinity DataIC50: 6.04E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233807(CHEMBL4078844 | US11021454, Compound 6c)
Affinity DataIC50: 6.36E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233808(CHEMBL4086701 | US11021454, Compound 6e)
Affinity DataIC50: 6.47E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233805(CHEMBL4077922 | US11021454, Compound Salvianolic a...)
Affinity DataIC50: 6.87E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233805(CHEMBL4077922 | US11021454, Compound Salvianolic a...)
Affinity DataIC50: 8.26E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233817(CHEMBL4095851 | US11021454, Compound 5d)
Affinity DataIC50: 8.66E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233754(CHEMBL4085672 | US11021454, Compound 5a)
Affinity DataIC50: 8.79E+3nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233754(CHEMBL4085672 | US11021454, Compound 5a)
Affinity DataIC50: 9.88E+3nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233802(CHEMBL4077819 | US11021454, Compound 5c)
Affinity DataIC50: 1.08E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233802(CHEMBL4077819 | US11021454, Compound 5c)
Affinity DataIC50: 1.20E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233815(CHEMBL4071391 | US11021454, Compound 6b)
Affinity DataIC50: 1.21E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233800(CHEMBL4074420 | US11021454, Compound 5f)
Affinity DataIC50: 1.24E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233801(CHEMBL4101163 | US11021454, Compound 5e)
Affinity DataIC50: 1.35E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500007(US11021454, Compound 9a)
Affinity DataIC50: 1.45E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233817(CHEMBL4095851 | US11021454, Compound 5d)
Affinity DataIC50: 1.49E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500009(US11021454, Compound 10a)
Affinity DataIC50: 1.72E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500008(US11021454, Compound 9b)
Affinity DataIC50: 1.90E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233800(CHEMBL4074420 | US11021454, Compound 5f)
Affinity DataIC50: 3.17E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50233801(CHEMBL4101163 | US11021454, Compound 5e)
Affinity DataIC50: 4.73E+4nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50142500(L-methionine | (2S)-2-amino-4-(methylsulfanyl)buta...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50109609(L-cysteine | (2R)-2-amino-3-mercaptopropanoic acid...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM18129((2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid | L...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM21974((2S)-2-amino-3-(1H-indol-3-yl)propanoic acid | CHE...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM50000099((S)-alanine | CHEMBL279597 | Ala | (S)-2-aminoprop...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM18073(L-[2,3,4,5,6-3H]phenylalanine | (2S)-2-amino-3-phe...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500011(US11021454, Compound D-dopa | US20240415800, Compo...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM60928(L-DOPA | dihydroxyphenylalanine | BDBM50130192 | L...)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500009(US11021454, Compound 10a)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500008(US11021454, Compound 9b)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500007(US11021454, Compound 9a)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500006(US11021454, Compound 7)
Affinity DataIC50: 6.00E+4nMAssay Description:11.1 Preparation of Reagents and Standard Solutions(1) 75 mM phosphate buffer (PB, pH 7.4): containing KH2PO4 0.0956 g, K2HPO4 0.6946 g, EDTA 1.862 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent

TargetXanthine dehydrogenase/oxidase(Human)
China Pharmaceutical University

US Patent
LigandPNGBDBM500006(US11021454, Compound 7)
Affinity DataIC50: 1.00E+5nMAssay Description:12.1 Preparation of Reagents and Standard Solutions(1) Preparation of DPPH solution: accurately weigh the appropriate amount of DPPH, add MeOH and pe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/28/2021
Entry Details
Go to US Patent